CVS Health (CVS): One of the Best Blue Chip Stocks Under $100 to Buy Now

CVS Health Corporation (NYSE:CVS) is one of the Best Blue Chip Stocks Under $100 to Buy Now. On June 1, Truist lifted its price objective on the company’s stock to $108 from $102 and maintained a “Buy” rating on the shares. This forms part of the research note on the broader managed healthcare companies. The analyst highlighted that the firm expects significant embedded earnings potential that is associated with the ongoing margin recovery throughout the government businesses.

CVS Health (CVS): One of the Best Blue Chip Stocks Under $100 to Buy Now

Furthermore, there are expectations of continued robust trends in the commercial business. The firm added that the Q1 medical cost trends were favourable to the consensus expectations of the analysts.

Notably, in Q1 2026, CVS Health Corporation (NYSE:CVS)’s total revenues came in at $100.4 billion, reflecting a rise of 6.2% YoY, with GAAP diluted EPS coming at $2.30 and adjusted EPS at $2.57. The company raised its FY 2026 guidance, with GAAP diluted EPS now expected to be between $6.24 – $6.44 compared to the previous range of $5.94 – $6.14.

CVS Health Corporation (NYSE:CVS) offers health solutions.

While we acknowledge the risk and potential of CVS as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than CVS and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 10 Best FMCG Stocks to Invest In According to Analysts and 11 Best Long-Term Tech Stocks to Buy According to Analysts.

Disclosure: None. Follow Insider Monkey on Google News.

1281292 - 11759070 - 1